Differential Use of Partial Nephrectomy for Intermediate and High Complexity Tumors May Explain Variability in Reported Utilization Rates-Reference-Cited by-同舟云学术

Differential Use of Partial Nephrectomy for Intermediate and High Complexity Tumors May Explain Variability in Reported Utilization Rates

Published:2013-06 Issue:6 Volume:189 Page:2047-2053
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Lane Brian R.¹,Golan Shay²,Eggener Scott²,Tobert Conrad M.¹,Kahnoski Richard J.¹,Kutikov Alexander³,Smaldone Marc³,Whelan Christopher M.¹,Shalhav Arieh²,Uzzo Robert G.³

Affiliation:

1. Spectrum Health Hospital System and Michigan State University College of Human Medicine, Grand Rapids, Michigan

2. University of Chicago, Chicago, Illinois

3. Fox Chase Cancer Center, Philadelphia, Pennsylvania

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Guideline for management of the clinical T1 renal mass;Campbell;J Urol,2009

2. A non-cancer-related survival benefit is associated with partial nephrectomy;Sun;Eur Urol,2012

3. Should partial nephrectomy be offered to all patients whenever technically feasible?;Kutikov;Eur Urol,2012

4. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer;Tan;JAMA,2012

5. Partial nephrectomy for small renal masses: an emerging quality of care concern?;Miller;J Urol,2006

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can automated CT body composition analysis predict high-grade Clavien–Dindo complications in patients with RCC undergoing partial and radical nephrectomy?;Scottish Medical Journal;2023-03-22

2. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group;World Journal of Urology;2023-03-01

3. Trends and safety of robot‐assisted partial nephrectomy during the initial 2‐year period after government approval in Japan: A nationwide database study from 2016 to 2018;International Journal of Urology;2021-09-15

4. Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study;EUR UROL FOCUS;2021

5. Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study;European Urology Focus;2021-07